A Study of Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV Drugs - Contacts and Locations

Home

A Study of Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV Drugs

This study has been completed.

Study NCT00002217. Last updated on June 23, 2005. Information provided by NIH AIDS Clinical Trials Information Service

Please refer to this study by its ClinicalTrials.gov identifier: NCT00002217

Locations


United States, Pennsylvania
	Anderson Clinical Research
	Pittsburgh, Pennsylvania, United States, 15213

Sponsors and Collaborators

Glaxo Wellcome